Localised and unresectable neuroblastoma in infants: Excellent outcome with low-dose primary chemotherapy

British Journal of Cancer

Volumn 89, Issue 9, 2003, Pages 1605-1609

  Rubie, H ^a   Coze, C ^b   Plantaz, D ^c   Munzer, C ^a   Defachelles, A S ^d   Bergeron, C ^e   Thomas, C ^f   Chastagner, P ^g   Valteau Couanet, D ^h   Michon, J ⁱ   Mosseri, V ⁱ   Hartmann, O ^h  

^a HÔPITAL DES ENFANTS   (France)

^b TIMONE HOSPITAL   (France)

^c CHU La Tronche and University   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e CENTRE LÉON BÉRARD   (France)

^f HÔTEL DIEU   (France)

^g HÔPITAL D ENFANTS   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ INSTITUT CURIE   (France)

Author keywords

Chemotherapy; Infants; Neuroblastoma; Unresectable

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; EXCISION; FOLLOW UP; GENE AMPLIFICATION; HUMAN; IMAGING SYSTEM; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; ONCOGENE C MYB; POSTOPERATIVE CARE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SALVAGE THERAPY; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; GENES, MYC; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0344440998     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601259     Document Type: Article

References (21)

1. Bernstein ML, Leclerc JM, Bunin G, Brisson L, Robison L, Shuster L, Byme T, Gregory D, Hill G, Dougherty G, Scriver C, Lemieux B, Tuchman M, Woods WG (1992) A population-based study of neuroblastoma incidence, survival and mortality in North America. J Clin Oncol 10: 323-329
2. Bergeron C, Chastagner P, Mechinaud F, Plouvier E, Defachelles AS, Dusol F, Pautard B, Edan C, Portas M, Deville A, Plantaz D, Dubourg L, Froehlich P, Rubie H (2000) Long-term renal function and hearing toxicity of CBDCA in infants treated for localized neuroblastoma (LNB). Results of the SFOP NBL 90 study. Advances in Neurobiological Research Meeting, Philadelphia, 15-18 May 2000, PC 13
3. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee R, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seegher RC, Tschuda Y, Voute PA (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 11: 1466-1477
4. Cox DR (1977) The Analysis of Binary Data. London: Chapman & Hall
5. De Bernardi B, Conte M, Mancini A, Don Francesco A, Alvisi P, Toma P, Casale F, Montezemolo LC, Cornelli PE, Carli M, Tonini GP, Pession A, Giaretti W, Garaventa A, Marchese N, Magillo P, Nigro M, Kotitsa Z, Tamaro P, Tamburrini A, Rogers D, Bruzzi P (1995) Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13: 884-893
6. Evans AE, Albo V, D' Angio GJ, Finklesteinjz, Leiken S, Santulli T, Weiner J, Hammond GD (1976) Factors influencing survival of children with non metastatic neuroblastoma. Cancer 38: 661-666
7. Fleiss JI (1981) Statistical Methods for Rates and Proportions, 2nd ed. New York: Wiley
8. Garaventa A, De Bernardi B, Pianca C, Donfrancesco A, Montezemolo LC, Di Tullio MT, Bagnulo S, Mancini A, Carli M, Pession A, Arrighini A, Di Cataldo A, Tamaro P, Iasonni V, Taccone A, Rogers D, Boni L (1993) Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. J Clin Oncol 11: 1770-1779
9. Haase GM, Wong KY, De Lorimier AA, Sather HN, Hammond GD (1989) Improvement in survival after excision of primary tumour in Stage III neuroblastoma. J Pediatr Surg 24: 194-200
10. Hartmann O, Scopinaro M, Tournade MF, Sarrazin D, Lemerle J (1983) Neuroblastomes traités à l' Institut Gustave Roussy de 1975 à 1979. Cent soixante treize cas. Arch Fr Pédiatr 40: 15-21
11. Hero B, Simon T, Benz-Bohm G, Scheel-Walter HG, Schilling FH, Berthold F (2002) Incidence and time frame of regression in stage 2 and stage 3 neuroblastoma. Advances in Neurobiological Research Meeting, Paris, 17-19 June 2002, OC 05
12. Kushner BH, Cheung NKV, Laquaglia MP, Ambros PF, Ambros IM, Bonilla MA, Gerald WL, Ladanyi M, Gilbert F, Rosenfield NS, Yeh SDJ (1996) Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14: 373-381
13. Le Tourneau JN, Bernard JL, Hendren WH, Carcassonne M (1985) Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 20: 244-249
14. Peto R, Mcpherson K, Peto J (1977) Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 35: 1-39
15. Plantaz D, Rubie H, Michon, Mechinaud F, Coze C, Chastagner P, Frappaz D, Gigaud M, Passagia JM, Hartmann O (1996) The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 cases. Results of the NBL 90 study of the French Society of Paediatric Oncology. Cancer 78: 311-319
16. Rosen EM, Cassady JR, Kretschmar C, Frantz CR, Levey R, Sallan SE (1984) Influence of loco-regional lymph nodes metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12: 260-264
17. Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet Loiseau H, Benard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle , Sommelet D (1997) Localized neuroblastoma: N-Myc gene amplification is a major prognostic factor. Results of the French NBL 90 study. J Clin Oncol 15: 1171-1182
18. Rubie H, Michon J, Plantaz D, Peyroulet MC, Coze C, Frappaz D, Chastagner P, Baranzelli MC, Mechinaud F, Boutard P, Lutz P, Perel Y, Leverger G, De Lumley L, Millot F, Stephan JL, Margueritte G, Hartmann O (1998) Unresectable localized neuroblasroma: improved survival after primary chemotherapy including carboplatin - etoposide. Br J Cancer 77: 2310-2317
19. Rubie H, Plantaz D, Coze C, Michon J, Frappaz D, Baranzelli MC, Chastagner P, Peyroulet MC, Hartmann O (2001) Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Med Pediatr Oncol 36: 247-250
20. Tsuchida Y, Honna T, Kamii Y (1989) Radical excision of primary tumour and lymph nodes in advanced neuroblastoma: comparison with intensive chemotherapy. Pediatr Surg Int 6: 567-571
21. West DC, Shamberger RC, Macklis RM, Kosakewich HPW, Wayne AS, Kreissman SG, Korf BR, Lavally B, Grier HE (1993) Stage III neuroblastoma over 1 year at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 11: 84-90